Insulin-metformin combination therapy in obese patients with type 2 diabetes

Journal of Clinical Pharmacology

Volumn 42, Issue 1, 2002, Pages 89-94

  Jaber, Linda A ^a   Nowak, Sandra N ^a   Slaughter, Richard R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADULT; AGED; ANALYSIS OF VARIANCE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036137212     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270002042001010     Document Type: Article

References (20)

1. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus, progressive requirements for multiple therapies (UKPDS 49)
2. Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors
3. Veterans Affairs Cooperative Study on glycemic control and complications in type 2 diabetes (VACS DM): Results of the feasibility trial: Veterans Affairs Cooperative Study in type 2 diabetes
4. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus
5. Insulin therapy in type 2 diabetes
6. Insulin resistance a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
7. Hyperinsulinemia as an independent risk factor for ischemic heart disease
8. Intensive conventional insulin therapy for type 2 diabetes
9. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations
10. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients
11. The antihyperglycaemic effect of metformin: Therapeutic and cellular mechanisms
12. Metformin
13. Biguanides and NIDDM
14. Effect of intensive blood-glucose with metformin on complications in overweight patients with type 2 diabetes
15. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus
16. Efficacy of metformin in patients with noninsulin-dependent diabetes mellitus: The Multicenter Metformin Study Group
17. Glycosylated hemoglobin and plasma glycoprotein assays by affinity chromatography
18. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control
19. Metformin added to insulin therapy in poorly controlled type 2 diabetes
20. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients